Literature DB >> 3170669

Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detection.

C Haring1, C Humpel, B Auer, A Saria, C Barnas, W Fleischhacker, H Hinterhuber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3170669     DOI: 10.1016/s0378-4347(00)83902-x

Source DB:  PubMed          Journal:  J Chromatogr


× No keyword cloud information.
  6 in total

1.  Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age.

Authors:  C Haring; U Meise; C Humpel; A Saria; W W Fleischhacker; H Hinterhuber
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  EEG alterations in patients treated with clozapine in relation to plasma levels.

Authors:  C Haring; C Neudorfer; J Schwitzer; M Hummer; A Saria; H Hinterhuber; W W Fleischhacker
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

Review 3.  Clozapine plasma level monitoring: current status.

Authors:  T B Cooper
Journal:  Psychiatr Q       Date:  1996

Review 4.  Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia.

Authors:  A Fitton; R C Heel
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

5.  Rapid liquid chromatography/tandem mass spectrometer (LCMS) method for clozapine and its metabolite N-desmethyl clozapine (norclozapine) in human serum.

Authors:  L V Rao; M L Snyder; G M Vallaro
Journal:  J Clin Lab Anal       Date:  2009       Impact factor: 2.352

Review 6.  Pharmacokinetics and pharmacodynamics of clozapine.

Authors:  M W Jann; S R Grimsley; E C Gray; W H Chang
Journal:  Clin Pharmacokinet       Date:  1993-02       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.